Reply to correspondence on "Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients".
作者信息
Kim Beom Kyung
机构信息
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
出版信息
Clin Mol Hepatol. 2024 Oct;30(4):1044-1046. doi: 10.3350/cmh.2024.0584. Epub 2024 Jul 29.
Abstract
摘要
相似文献
1
Reply to correspondence on "Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients".对关于“慢性乙型肝炎患者长期抗病毒治疗后肝细胞癌预测模型性能下降”的通信的回复
Clin Mol Hepatol. 2024 Oct;30(4):1044-1046. doi: 10.3350/cmh.2024.0584. Epub 2024 Jul 29.
2
Correspondence to editorial on "Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients".致关于“慢性乙型肝炎患者长期抗病毒治疗后肝细胞癌预测模型性能下降”的社论的信函。
Clin Mol Hepatol. 2024 Oct;30(4):994-996. doi: 10.3350/cmh.2024.0552. Epub 2024 Jul 23.
3
Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients.长期抗病毒治疗会降低慢性乙型肝炎患者肝细胞癌预测模型的性能。
Clin Mol Hepatol. 2023 Jul;29(3):747-762. doi: 10.3350/cmh.2023.0121. Epub 2023 May 10.
4
Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind: Editorial on "Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients".乙型肝炎抗病毒治疗期间肝癌预测模型性能下降：还需谨记哪些要点：关于“慢性乙型肝炎患者长期抗病毒治疗导致肝细胞癌预测模型性能下降”的社论
Clin Mol Hepatol. 2024 Oct;30(4):656-658. doi: 10.3350/cmh.2024.0499. Epub 2024 Jul 8.
5
Risk predictive model for the development of hepatocellular carcinoma before initiating long-term antiviral therapy in patients with chronic hepatitis B virus infection.慢性乙型肝炎病毒感染患者开始长期抗病毒治疗前发生肝细胞癌的风险预测模型。
J Med Virol. 2024 Sep;96(9):e29884. doi: 10.1002/jmv.29884.
6
Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy.未接受抗病毒治疗的乙型肝炎病毒患者肝细胞癌累积发病率的长期随访。
World J Gastroenterol. 2021 Mar 21;27(11):1101-1116. doi: 10.3748/wjg.v27.i11.1101.
7
Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis.抗病毒治疗与肝硬化乙肝患者肝细胞癌风险
Eur J Gastroenterol Hepatol. 2020 Sep;32(9):1207-1211. doi: 10.1097/MEG.0000000000001639.
8
Antiviral therapy decreases viral reactivation in patients with hepatitis B virus-related hepatocellular carcinoma undergoing hepatectomy: a randomized controlled trial.抗病毒治疗可降低行肝切除术的乙型肝炎病毒相关肝细胞癌患者的病毒再激活：一项随机对照试验。
J Viral Hepat. 2013 May;20(5):336-42. doi: 10.1111/jvh.12036. Epub 2012 Dec 5.
9
Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment.慢性乙型肝炎在有效的抗病毒治疗后，其肝硬化患者发生肝细胞癌的发生率高于丙型肝炎。
J Formos Med Assoc. 2021 Jan;120(1 Pt 3):621-628. doi: 10.1016/j.jfma.2020.07.019. Epub 2020 Jul 24.
10
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.长期使用富马酸替诺福韦二吡呋酯对慢性乙型肝炎患者肝细胞癌发生率的影响。
Cancer. 2015 Oct 15;121(20):3631-8. doi: 10.1002/cncr.29537. Epub 2015 Jul 15.
引用本文的文献
1
Prediction Model for Familial Aggregated HBV-Associated Hepatocellular Carcinoma Based on Serum Biomarkers.基于血清生物标志物的家族聚集性乙肝相关肝细胞癌预测模型
Cancer Rep (Hoboken). 2025 Jun;8(6):e70253. doi: 10.1002/cnr2.70253.
本文引用的文献
1
Correspondence to editorial on "Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients".致关于“慢性乙型肝炎患者长期抗病毒治疗后肝细胞癌预测模型性能下降”的社论的信函。
Clin Mol Hepatol. 2024 Oct;30(4):994-996. doi: 10.3350/cmh.2024.0552. Epub 2024 Jul 23.
2
Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind: Editorial on "Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients".乙型肝炎抗病毒治疗期间肝癌预测模型性能下降：还需谨记哪些要点：关于“慢性乙型肝炎患者长期抗病毒治疗导致肝细胞癌预测模型性能下降”的社论
Clin Mol Hepatol. 2024 Oct;30(4):656-658. doi: 10.3350/cmh.2024.0499. Epub 2024 Jul 8.
3
Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC.对比非对比性简化磁共振成像和超声作为 HCC 的监测手段。
J Hepatol. 2024 Sep;81(3):461-470. doi: 10.1016/j.jhep.2024.03.048. Epub 2024 Apr 16.
4
Radiomics and liver: Where we are and where we are headed?放射组学与肝脏：我们所处的位置以及前进的方向？
Eur J Radiol. 2024 Feb;171:111297. doi: 10.1016/j.ejrad.2024.111297. Epub 2024 Jan 12.
5
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.纳入中度乙肝病毒脱氧核糖核酸水平的PAGE-B可预测HBeAg阳性慢性乙型肝炎患者发生肝细胞癌的风险。
J Hepatol. 2024 Jan;80(1):20-30. doi: 10.1016/j.jhep.2023.09.011. Epub 2023 Sep 19.
6
Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signatures.基于纵向数据和游离DNA特征的新型高精度肝细胞癌预测模型。
J Hepatol. 2023 Oct;79(4):933-944. doi: 10.1016/j.jhep.2023.05.039. Epub 2023 Jun 10.
7
Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients.长期抗病毒治疗会降低慢性乙型肝炎患者肝细胞癌预测模型的性能。
Clin Mol Hepatol. 2023 Jul;29(3):747-762. doi: 10.3350/cmh.2023.0121. Epub 2023 May 10.
8
A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study.基于T2加权成像的新型放射组学特征可准确预测经活检证实的非酒精性脂肪性肝病患者的肝脏炎症：一项推导和独立验证研究。
Hepatobiliary Surg Nutr. 2022 Apr;11(2):212-226. doi: 10.21037/hbsn-21-23.
9
External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study.使用慢性乙型肝炎患者无创纤维化标志物治疗期间变化对FSAC模型进行外部验证：一项多中心研究
Cancers (Basel). 2022 Jan 29;14(3):711. doi: 10.3390/cancers14030711.
10
A Combination Model of Radiomics Features and Clinical Biomarkers as a Nomogram to Differentiate Nonadvanced From Advanced Liver Fibrosis: A Retrospective Study.基于放射组学特征与临床生物标志物的联合模型构建列线图以鉴别非进展性与进展性肝纤维化：一项回顾性研究。
Acad Radiol. 2021 Nov;28 Suppl 1:S45-S54. doi: 10.1016/j.acra.2020.08.029. Epub 2021 May 19.
Zotero 插件